CLBNManagementbusinesswire

Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer

Sentiment:Negative (20)

Summary

CLEVELAND--(BUSINESS WIRE)--Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors. He will assume his responsibilities on August 18, 2025. Mr. Dillon succeeds Gulam Khan, who has served as CEO since October 2022. Mr. Khan led Centerline Biomedical through a period of portfolio development. During his tenu

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 18, 2025 by businesswire